5[2]Kloner RA,Ganole CE,Jeunjngs RR,et al.The no reflow pbeomnenon after temporary coronary occlusion in the dogs[J].J Clin Invest,1974,54(6):1496-1508.
6[3]Mizote IU,Eda Y,Ohtani T,et al.Distal protection inproved reperfrsion and reduced left ventricular dysfunction in patients w ith acute myocardial in farction who had angioscoically ddined inptured plaque[J].Circulation,2005,112(7):1001-1007.
7[4]Larde K,Besrchaxnp P,Thuillez C,et al.Endothelial protective effects of preconditiong[J].Cardiovasc Res 2002,55(3):466-473.
8[5]Kemper AJ,O' Boyle JE,Cohen CA,et al.Hydrogen peroride comtrast echocardiography quantification in vlvo of myocardial risk area following torbmy occlasion and necotic area iunaining after myocandial reprefusion[J].Gicabtin,1984,70(2):309-317.
9[6]Molitemo DJ.Chan AW.Glycoptotein Ⅱ b/Ⅲa inhibition in early internal to stent treament of acute coronary syndromes[J].J Am Coll Cardiol,2003,41:49-54.
10[7]Antoniucci D,Migliorini A,Panodi G,et al.Abeciximab supported infarct artery stent implantation for acute myocardial infarction and long-term survival:a prospective muhicenter randomized trial comparison infatet artery stenting plus abciximab with stenting alone[J].Circu-lation 2004,109(14):1704-1706.
